These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28152063)

  • 21. Predicting treatment response using EEG in major depressive disorder: A machine-learning meta-analysis.
    Watts D; Pulice RF; Reilly J; Brunoni AR; Kapczinski F; Passos IC
    Transl Psychiatry; 2022 Aug; 12(1):332. PubMed ID: 35961967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment.
    Zhou S; Ma Q; Lou Y; Lv X; Tian H; Wei J; Zhang K; Zhu G; Chen Q; Si T; Wang G; Wang X; Zhang N; Huang Y; Liu Q; Yu X
    J Affect Disord; 2021 May; 287():372-379. PubMed ID: 33836365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute trajectories of neural activation predict remission to pharmacotherapy in late-life depression.
    Karim HT; Wang M; Andreescu C; Tudorascu D; Butters MA; Karp JF; Reynolds CF; Aizenstein HJ
    Neuroimage Clin; 2018; 19():831-839. PubMed ID: 30013927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of rTMS treatment response in major depressive disorder using machine learning techniques and nonlinear features of EEG signal.
    Hasanzadeh F; Mohebbi M; Rostami R
    J Affect Disord; 2019 Sep; 256():132-142. PubMed ID: 31176185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatial-Temporal EEG Fusion Based on Neural Network for Major Depressive Disorder Detection.
    Zhang B; Wei D; Yan G; Li X; Su Y; Cai H
    Interdiscip Sci; 2023 Dec; 15(4):542-559. PubMed ID: 37140772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.
    Arns M; Bruder G; Hegerl U; Spooner C; Palmer DM; Etkin A; Fallahpour K; Gatt JM; Hirshberg L; Gordon E
    Clin Neurophysiol; 2016 Jan; 127(1):509-519. PubMed ID: 26189209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major Depressive Disorder Classification Based on Different Convolutional Neural Network Models: Deep Learning Approach.
    Uyulan C; Ergüzel TT; Unubol H; Cebi M; Sayar GH; Nezhad Asad M; Tarhan N
    Clin EEG Neurosci; 2021 Jan; 52(1):38-51. PubMed ID: 32491928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The implication of functional connectivity strength in predicting treatment response of major depressive disorder: a resting EEG study.
    Lee TW; Wu YT; Yu YW; Chen MC; Chen TJ
    Psychiatry Res; 2011 Dec; 194(3):372-377. PubMed ID: 22041534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detrended fluctuation analysis for major depressive disorder.
    Mumtaz W; Malik AS; Ali SS; Yasin MA; Amin H
    Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():4162-5. PubMed ID: 26737211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor in patients with major depressive disorder.
    Wu EQ; Yu AP; Lauzon V; Ramakrishnan K; Marynchenko M; Ben-Hamadi R; Blum S; Erder MH
    Ann Pharmacother; 2011 Apr; 45(4):441-51. PubMed ID: 21415162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of ethyl cysteinate dimer single photon emission computed tomography in predicting antidepressant treatment response in patients with major depression.
    Hanada H; Imanaga J; Yoshiiwa A; Yoshikawa T; Tanaka Y; Tsuru J; Inoue A; Ishitobi Y; Okamoto S; Kanehisa M; Maruyama Y; Ninomiya T; Higuma H; Isogawa K; Kawasaki T; Fujioka T; Akiyoshi J
    Int J Geriatr Psychiatry; 2013 Jul; 28(7):756-65. PubMed ID: 23007970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.
    Bares M; Brunovsky M; Kopecek M; Novak T; Stopkova P; Kozeny J; Sos P; Krajca V; Höschl C
    Eur Psychiatry; 2008 Aug; 23(5):350-5. PubMed ID: 18450430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.
    Caudill MM; Hunter AM; Cook IA; Leuchter AF
    Clin EEG Neurosci; 2015 Oct; 46(4):277-84. PubMed ID: 25258429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A feature extraction technique based on tunable Q-factor wavelet transform for brain signal classification.
    Al Ghayab HR; Li Y; Siuly S; Abdulla S
    J Neurosci Methods; 2019 Jan; 312():43-52. PubMed ID: 30468823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An EEG-based machine learning method to screen alcohol use disorder.
    Mumtaz W; Vuong PL; Xia L; Malik AS; Rashid RBA
    Cogn Neurodyn; 2017 Apr; 11(2):161-171. PubMed ID: 28348647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of Depression Patients and Normal Subjects Based on Electroencephalogram (EEG) Signal Using Alpha Power and Theta Asymmetry.
    Mahato S; Paul S
    J Med Syst; 2019 Dec; 44(1):28. PubMed ID: 31834531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Classification of EEG signals using neural network and logistic regression.
    Subasi A; Erçelebi E
    Comput Methods Programs Biomed; 2005 May; 78(2):87-99. PubMed ID: 15848265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.